Varian Medical Systems
The 10-second takeaway
For the quarter ended Dec. 30 (Q1), Varian Medical Systems met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue improved, and earnings per share dropped slightly.
Margins contracted across the board.
Varian Medical Systems booked revenue of $625.3 million. The 12 analysts polled by S&P Capital IQ expected revenue of $633.1 million. Sales were 7.8% higher than the prior-year quarter's $579.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.
EPS came in at $0.79. The 14 earnings estimates compiled by S&P Capital IQ averaged $0.75 per share. GAAP EPS of $0.79 for Q1 were 1.3% lower than the prior-year quarter's $0.80 per share.
Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.
For the quarter, gross margin was 43%, 300 basis points worse than the prior-year quarter. Operating margin was 20.6%, 300 basis points worse than the prior-year quarter. Net margin was 14.4%, 220 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $713.3 million. On the bottom line, the average EPS estimate is $1.00.
Next year's average estimate for revenue is $2.85 billion. The average EPS estimate is $3.98.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 384 members out of 399 rating the stock outperform, and 15 members rating it underperform. Among 135 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 134 give Varian Medical Systems a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Varian Medical Systems is outperform, with an average price target of $69.93.
The healthcare investing landscape is littered with also-rans and a few major winners. Is Varian Medical Systems the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will be a phenomenal success over the next few years. Click here for instant access to this free report.
- Add Varian Medical Systems to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.